Vericel Corporation(NASDAQ:VCEL) 
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellula...
Website: http://vcel.com
Founded: 1989
Full Time Employees: 241
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 42.72
H 43.12
L 41.37
C 41.92
V 768,773
10EMA 41.92
20EMA 41.92
60EMA 41.92
120EMA 41.92
250EMA 41.92